Remote Assessment of Disease and Relapse – Central Nervous System (RADAR-CNS) is an international research programme exploring the potential of wearable devices to help prevent and treat depression, multiple sclerosis and epilepsy. This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115902. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA. See www.imi.europa.eu for more details.
| Website | http://www.radar-cns.org/ |
| Revenue | $6.6 million |
| Employees | 1 (1 on RocketReach) |
| Founded | 2016 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+18 more
(view full list)
|
| Industry | Research Services, Pharmaceuticals, Healthcare |
| Keywords | Wearable Technology, Central Nervous System, Remote Patient Monitoring, Disease Prevention, Neurological Disorders, Health Technology, Depression Treatment, Multiple Sclerosis Research, Epilepsy Research, Medical Devices, Digital Health, Clinical Research, Wearable Sensors, Relapse Prevention, Early Detection, Disease Management, Telemedicine, Data Analytics, Patient Care, Biomedical Engineering |
| Competitors | Ginger, Mindstrong Health, Deloitte, Pear Therapeutics, Livongo, Headspace, Happify, Komodo Health, Welldoc, hims & hers +44 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies |
Looking for a particular RADAR-CNS employee's phone or email?
The RADAR-CNS annual revenue was $6.6 million in 2026.
1 people are employed at RADAR-CNS.
The NAICS codes for RADAR-CNS are [3254, 32541, 32, 325].
The SIC codes for RADAR-CNS are [28, 283].